About Progentos Therapeutics
Progentos Therapeutics is a private company based in Watertown, Massachusetts, incorporated in 2023 in Delaware. It has reported $68,588,739 raised in one offering on Form D since May 2024. Its chief executive is Christopher Loose.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 3, 2024 | May 17, 2024 | $68,588,739fully sold | 39 | $1.7M | Equity, Includes conversion of convertible notesRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Progentos Therapeutics's Form D filed May 17, 2024.
AM
Aleks Radovic-Moreno
Director
DH
DJ
Dan Janney
Director
CL
Christopher Loose
CEO and director
CB
Cassidy Blundell
Director
SM
Sanjay Magavi
Executive officer
MT
Marc-Olivier Turgeon
Director